Lithium Ion

Lithium Ion

SCHEMBL1077860

COc1cc(C(=O)[O-])c2c(CCN[C@@H]3CN4CCC3CC4)n[nH]c2c1.[Li+]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.36
HTR3A P46098 7/20 0.36
CHRNA7 P36544 3/20 0.36
HTR3E A5X5Y0 2/20 0.34
HTR3B O95264 2/20 0.34
HTR3D Q70Z44 2/20 0.34
HTR3C Q8WXA8 2/20 0.34
HTR5A P47898 1/20 0.34
MEN1 O00255 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPK1 P28482 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1080364 0.91 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
SCHEMBL9231237 0.91 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
SCHEMBL9231230 0.91 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
SCHEMBL1080362 0.91 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
SCHEMBL1077863 0.90 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
Lithium Ion SCHEMBL1081156 0.83 CHRNA7 (0.45) SIGMAR1HTR3ACHRNA7
SCHEMBL1079421 0.81 SIGMAR1 (0.38) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
SCHEMBL1079419 0.81 SIGMAR1 (0.38) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
Hydrochloric Acid SCHEMBL13387323 0.80 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B
Hydrochloric Acid SCHEMBL13387322 0.80 SIGMAR1 (0.37) SIGMAR1HTR3ACHRNA7HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011008572-A2 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-20 WO disclosed